As one of the 15 new drug creation platforms in the country，The distinctive characteristics of the "Eleventh Five -Year Plan" national science and technology major special special specialized "Shandong Provincial New Medicine Creation Center Construction Project" with the Shandong Provincial Government "。
Qilu Pharmaceuticals stand out
Since the implementation of the project，10 items of technological innovation platforms at or above the provincial and ministerial level at or above the stake betting appMy stake betting appconstruction unit，Total 38 items。Where，The backbone pharmaceutical enterprises cultivated by major special specialized specialized in technology are developing the fastest。The sales revenue of Qilu Pharmaceutical Group, a large platform industrialization demonstration enterprise, exceeds 5 billion yuan，List 4th in the sales ranking of Chinese hospitals，Pick up the beam among 20 industrialized demonstration companies。
Qilu Pharmaceuticals can stand out from many domestic pharmaceutical companies，Especially in foreign capital、Getting good achievements under the enclosure of joint venture，On the one hand, it is power to support the country's innovation of new drugs，On the one hand, due to the years of unremitting innovation strategy，The secret of success is mainly summarized as "new、All、Excellent "3 words。Qilu Pharmaceutical has the latest product resources，If Anti -acute heart failure medicine Zuoxi Meng Dan、Reorganized human granulocyte stimulation factor、Reorganized Bai Jiewa-11, etc.; there are rich product lines，Can fully cover all fields; depending on the quality of the product is life，It is the only company in China that has passed the American sterile ingredient certification，Obtaining 5 EU COS Certificate in 2009。At the same time，The R & D Line has always been continuously transporting stake betting appnew products to the market，Stake Sports Betting2009 ~ 2010，Qilu Pharmaceutical invested 1.6 billion yuan，Increase the infrastructure of the 8 major scientific research and production bases。2010，154 items in the development state，New project 42 items，9 approved production projects，9 clinical approval，Application of 12 production projects。To adapt to the new changes in the market，Realize the sustainable enterprise、Healthy Development，In recent years，Qilu Pharmaceutical has achieved gorgeous turn on the strategic level of the enterprise，Let 16 subsidiaries be set down，8 major scientific research、Production base，Develop the product line to the current anti -infection、Tumor、Spiritual nerve、Cardiovascular、Five areas of cerebrovascular。
The results of the new drug creation project Pei Ran
"Shandong Provincial Major New Medicine Creation Center Construction Project" established a systematic biomedical technology standard specification，4 Unit technology platforms that are in line with international standards，Started a construction project of 290,000 square meters in the central area of the large platform。Through the "Jinan High -tech Zone as the center，The ‘one area connected to the technical chain and the industrialized chain、6 bases、Twenty demonstration companies、Thirty high stake betting app-end R & D teams、Three New Pharmaceutical Industry My stake betting appDental Area "" is the construction of the new drug creation system for the main content，formed a relatively concentrated area、Completion of service capabilities、Modern new drug research and results conversion system with advanced domestic advanced levels，Constructed a new medicine discovery、Filter、Evaluation、New pre -clinical research on the trial research、Process research and other industrialized development of major new drug creation technology support system，strongly promoted the development of biomedical enterprises in the province，Initially formed Luzhong、Lunan、Three pharmaceutical industry dense areas。
Enterprises with sales revenue of over 100 million yuan in the province reached 80，26 more than 500 million yuan，20 of over 1 billion yuan，10 of over 2 billion yuan，over 3 billion yuan 5，3 of over 4 billion yuan，1 one with over 5 billion yuan。15 companies enter the top 100 national pharmaceutical industry sorted by the total assets; 17 companies enter the top 100 national pharmaceutical industry in accordance with the main business income;。In addition，Cultivate 28 varieties of new drugs; 6 large varieties with sales income of 500 million yuan，2 of over 1 billion yuan。64 countries with basic drugs and domestic market share with a output value of more than 30 stake betting appmillion yuan in Shandong Province are 64，16 varieties My stake betting appof domestic market share first。
(Man Yong)
